(SOLB) Solvay - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003470755
SOLB: Sodium Carbonate, Sodium Bicarbonate, Hydrogen Peroxide, Silica, Solvents
Solvay SA is a global leader in the production of specialized chemicals, operating since 1863 with its headquarters in Brussels, Belgium. The company specializes in manufacturing essential chemical products such as soda ash (sodium carbonate), sodium bicarbonate, hydrogen peroxide, and precipitated silica, which are critical components in various industries. Its product portfolio serves diverse sectors, including glass manufacturing for construction, solar panels, and packaging; lithium-ion batteries for electric vehicles; detergents; healthcare; food and animal feed; and water treatment. Solvay also produces solvents and polyamide chain products used in paints, hygiene, and home care applications, as well as fluorine and rare-earth formulations for automotive, electronics, and niche industrial applications.
The company’s soda ash is a cornerstone product, used in glass production for automotive windshields, architectural glass, and solar panels. Sodium bicarbonate, another key product, is utilized in food and animal feed, flue gas treatment, and pharmaceuticals. Solvay’s hydrogen peroxide is applied across multiple industries, including pulp and paper, textiles, water treatment, and the production of semiconductors and batteries. Precipitated silica is a critical component in tire manufacturing, personal care products, and food additives. The company’s polyamide chain products are integral to the production of engineering plastics and fibers, while its fluorine derivatives are used in refrigerants, air conditioning, and lithium-ion battery electrolytes.
Additional Sources for SOLB Stock
SOLB Stock Overview
| Market Cap in USD | 3,967m |
| Sector | Basic Materials |
| Industry | Chemicals |
| GiC Sub-Industry | Diversified Chemicals |
| IPO / Inception |
SOLB Stock Ratings
| Growth Rating | 74.0 |
| Fundamental | 5.08 |
| Dividend Rating | 47.4 |
| Rel. Strength | -1.62 |
| Analysts | - |
| Fair Price Momentum | 38.02 EUR |
| Fair Price DCF | 62.22 EUR |
SOLB Dividends
| Dividend Yield 12m | 10.52% |
| Yield on Cost 5y | 46.69% |
| Annual Growth 5y | -8.31% |
| Payout Consistency | 93.8% |
SOLB Growth Ratios
| Growth Correlation 3m | -19% |
| Growth Correlation 12m | 1.5% |
| Growth Correlation 5y | 94.8% |
| CAGR 5y | 33.44% |
| CAGR/Max DD 5y | 1.30 |
| Sharpe Ratio 12m | 0.39 |
| Alpha | -13.62 |
| Beta | 0.354 |
| Volatility | 43.87% |
| Current Volume | 331.7k |
| Average Volume 20d | 141.1k |
As of May 16, 2025, the stock is trading at EUR 30.28 with a total of 331,720 shares traded.
Over the past week, the price has changed by -1.11%, over one month by -4.60%, over three months by -8.08% and over the past year by -6.10%.
Neither. Based on ValueRay Fundamental Analyses, Solvay is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.08 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SOLB as of May 2025 is 38.02. This means that SOLB is currently undervalued and has a potential upside of +25.56% (Margin of Safety).
Solvay has no consensus analysts rating.
According to ValueRays Forecast Model, SOLB Solvay will be worth about 41.1 in May 2026. The stock is currently trading at 30.28. This means that the stock has a potential upside of +35.6%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 33.5 | 10.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41.1 | 35.6% |